Loading…
Operando characterization of rhodium catalyst degradation in hydroformylation
For a comprehensive understanding of catalyst stability, knowledge of deactivation processes is an important keystone in addition to activity and selectivity. The underlying mechanisms and kinetics of deactivation help to understand and control the formation of undesired byproducts, thus preventing...
Saved in:
Published in: | Catalysis science & technology 2023-03, Vol.13 (6), p.1788-1801 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | For a comprehensive understanding of catalyst stability, knowledge of deactivation processes is an important keystone in addition to activity and selectivity. The underlying mechanisms and kinetics of deactivation help to understand and control the formation of undesired byproducts, thus preventing a loss of selectivity. This work addresses catalyst deactivation in the homogeneously Rh/BiPhePhos-catalyzed hydroformylation of a long-chain olefin by hydroperoxides. Using
operando
FTIR spectroscopy, kinetic perturbation experiments with
tert
-butyl hydroperoxide were able to correlate the loss of regioselectivity in hydroformylation with the structural changes of the catalyst, providing evidence for degradation. Comparison of experimental and DFT calculated vibrational bands indicated the oxidative degradation of the diphosphite ligand and the formation of Rh carbonyl clusters. To predict a critical degradation of the ligand by hydroperoxides over time, which leads to a loss of regioselectivity, deactivation kinetics were derived and parameterized. The developed kinetic model of deactivation predicts the critical degradation of the ligand at different temperatures and concentrations of
tert
-butyl hydroperoxide well. It offers a model-based approach for process stabilization and optimization
e.g.
using ligand dosing strategies in the future. |
---|---|
ISSN: | 2044-4753 2044-4761 |
DOI: | 10.1039/D2CY01807A |